EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enzyme–DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs

Jillian F Armenia iD, Neil Osheroff iD

ACS Infectious Diseases · 13.02.2026 · 12 (2) · 816-826

DOI: 10.1021/acsinfecdis.5c01018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 27.01.2026. Verfasst von Jillian F Armenia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States. Hauptthemen laut MEDLINE: DNA Gyrase, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Mycobacterium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Division of Microbiology and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA GyraseAnti-Bacterial AgentsTopoisomerase II InhibitorsMycobacteriumDNA, BacterialFluoroquinolonesCiprofloxacinNaphthyridinesSpiro CompoundsMoxifloxacinDNA Topoisomerase IVBarbituratesIsoxazolesMorpholinesOxazolidinones

Stichwörter der Autor:innen

DNA decatenationDNA relaxationDNA supercoilingfluoroquinolonesgyrasespiropyrimidinetriones

Substanzen

DNA GyraseAnti-Bacterial AgentsTopoisomerase II InhibitorsFluoroquinoloneszoliflodacinCiprofloxacinNaphthyridinesSpiro CompoundsMoxifloxacinDNA, Bacterial

Autor:innen und Institutionen

  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232 United States.

ORCID-Profile: Jillian F Armenia, Neil Osheroff

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Division of Microbiology and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Armenia, J. F., & Osheroff, N. (2026). Enzyme–DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs. ACS Infectious Diseases, 12(2), 816-826. https://doi.org/10.1021/acsinfecdis.5c01018

Vancouver

Armenia JF, Osheroff N. Enzyme–DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs. ACS Infectious Diseases. 2026;12(2):816-826. doi:10.1021/acsinfecdis.5c01018

BibTeX
@article{Armenia2026,
  author = {Armenia, Jillian F and Osheroff, Neil},
  title = {Enzyme–DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {816--826},
  doi = {10.1021/acsinfecdis.5c01018}
}
Kostenlos starten →